Trending:
May 7, 2025, 04:29 PM - 3 min read
These policy moves aim to prioritise domestic manufacturing of pharmaceuticals in the United States and could reshape global drug supply chains if implemented strictly.
Read moreApril 4, 2025, 04:09 PM - 3 min read
The growth will mainly be driven by the robust performance in the domestic formulations (DF) and moderate improvement in US sales.
Read more